Safer supply and political interference in medical practice: Alberta's Narcotics Transition Services

Across much of Canada, opioid poisoning deaths have been increasing due to a toxic, contaminated, and unpredictable drug supply. Multiple prescribed safer supply pilot projects are being implemented and evaluated in an attempt to save lives. In the province of Alberta, however, new regulations introduced in 2022 significantly constrain safer supply prescribing by banning the prescription, dispensing, and administration of safer supply outside of a very limited number of clinics. In this commentary, we review prescribed safer supply programs in Canada and outline how the Alberta Government's change in regulations conflict with emerging evidence and efforts by other jurisdictions to address the rising opioid poisoning deaths. We examine the development of these regulations and analyze how the Alberta government shaped and justified this restrictive policy. We conclude by identifying important lessons learned from the experience in Alberta for researchers, healthcare providers, and decisionmakers in other jurisdictions.

Authors

Institutions

Publication Details

Journal
International Journal of Drug Policy
Published
2024-10-02
DOI
https://doi.org/10.1016/j.drugpo.2024.104600
Citations
9
Primary Topic
Opioid Use Disorder Treatment
Type
article
Field-Weighted Citation Impact
4.89
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Safer supply and political interference in medical practice: Alberta's Narcotics Transition Services

Patty Wilson, Kate Colizza, Elaine Hyshka
9 citations
International Journal of Drug Policy
Opioid Use Disorder Treatment
4.89
article

Safer supply and political interference in medical practice: Alberta's Narcotics Transition Services

Patty Wilson, Kate Colizza, Elaine Hyshka
article en
9 citations

Abstract

Across much of Canada, opioid poisoning deaths have been increasing due to a toxic, contaminated, and unpredictable drug supply. Multiple prescribed safer supply pilot projects are being implemented and evaluated in an attempt to save lives. In the province of Alberta, however, new regulations introduced in 2022 significantly constrain safer supply prescribing by banning the prescription, dispensing, and administration of safer supply outside of a very limited number of clinics. In this commentary, we review prescribed safer supply programs in Canada and outline how the Alberta Government's change in regulations conflict with emerging evidence and efforts by other jurisdictions to address the rising opioid poisoning deaths. We examine the development of these regulations and analyze how the Alberta government shaped and justified this restrictive policy. We conclude by identifying important lessons learned from the experience in Alberta for researchers, healthcare providers, and decisionmakers in other jurisdictions.

International Journal of Drug PolicyVol. 133
University of Calgary (CA)
Openalex Percentile: Top 4%
Opioid Use Disorder Treatment
4.89
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Safer supply and political interference in medical practice: Alberta's Narcotics Transition Services — Patty Wilson, Kate Colizza, et al. · International Journal of Drug Policy (2024) | TGRS Research Map | TGRS